India Precision Oncology Market Size & Outlook, 2025-2030
India Precision Oncology Market, 2018-2030 (US$M)
Global Market
Related Markets
India precision oncology market highlights
- The India precision oncology market generated a revenue of USD 4,363.5 million in 2024 and is expected to reach USD 8,900.9 million by 2030.
- The India market is expected to grow at a CAGR of 12.6% from 2025 to 2030.
- In terms of segment, therapeutics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Precision oncology market data book summary
| Market revenue in 2024 | USD 4,363.5 million |
| Market revenue in 2030 | USD 8,900.9 million |
| Growth rate | 12.6% (CAGR from 2025 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics |
Other key industry trends
- In terms of revenue, India accounted for 3.8% of the global precision oncology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan precision oncology market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,900.9 million by 2030.
The India precision oncology market is projected to grow at the fastest CAGR throughout the forecast period. The development of accessible and affordable innovative therapies in the country is exemplified by the launch of India’s first home-grown CAR-T cell therapy for cancer. This breakthrough gene therapy, launched in April 2024, is a significant advancement in cancer treatment, offering a promising option for patients who previously lacked access to such therapies due to high costs.
As CAR-T cell therapy becomes more affordable, it increases access to cutting-edge treatments, helping to address cancer in the Indian population. This initiative not only demonstrates the country's growing capabilities in biotechnology but also aligns with the broader movements, further driving the market growth in India.
No credit card required*
Publish Date: Jan 22, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Precision Oncology Market Scope
Precision Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Exact Sciences Corp | View profile | 6,600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | www.exactsciences.com |
| Invitae Corp | View profile | 1,700 | 1400 16th Street, San Francisco, CA, United States, 94103 | www.invitae.com |
| Rain Oncology | View profile | 101-250 | Newark, California, United States, North America | www.rainoncology.com |
| Strata Oncology | View profile | 51-100 | Ann Arbor, Michigan, United States, North America | www.strataoncology.com/ |
| Xilis | View profile | 51-100 | Durham, North Carolina, United States, North America | www.xilis.net |
| Variantyx | View profile | 101-250 | Framingham, Massachusetts, United States, North America | www.variantyx.com |
| BioServe | View profile | 51-100 | Beltsville, Maryland, United States, North America | bioserve.com |
India Precision Oncology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Precision Oncology Market Outlook will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 79.94% in 2024.
Horizon Databook has segmented the India precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The India precision oncology market is projected to grow at the fastest CAGR throughout the forecast period. The development of accessible and affordable innovative therapies in the country is exemplified by the launch of India’s first home-grown CAR-T cell therapy for cancer. This breakthrough gene therapy, launched in April 2024, is a significant advancement in cancer treatment, offering a promising option for patients who previously lacked access to such therapies due to high costs.
As CAR-T cell therapy becomes more affordable, it increases access to cutting-edge treatments, helping to address cancer in the Indian population. This initiative not only demonstrates the country's growing capabilities in biotechnology but also aligns with the broader movements, further driving the market growth in India.
- India Precision Oncology Market Product Outlook (Revenue, USD Million , 2018-2030)
- Diagnostics
- Therapeutics
- India Precision Oncology Market Cancer Outlook (Revenue, USD Million , 2018-2030)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Prostate Cancer
- Lung Cancer
- Others
- India Precision Oncology Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Healthcare Data Companies
Reasons to subscribe to Precision Oncology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Precision Oncology Market Outlook databook
- Our clientele includes a mix of Precision Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Precision Oncology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Precision Oncology Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
India Precision Oncology Market, 2018-2030 (US$M)
India Product - Precision Oncology Market Statistics, 2024 - 2030 (US$M)
